Provided by Tiger Fintech (Singapore) Pte. Ltd.

BeiGene

184.71
+0.0000
Volume:- -
Turnover:61.43M
Market Cap:19.67B
PE:-22.56
High:184.71
Open:184.71
Low:184.71
Close:184.71
Loading ...

Sector Update: Health Care Stocks Advance Pre-Bell Thursday

MT Newswires Live
·
14 Nov 2024

BeiGene Proposes Name Change

MT Newswires Live
·
14 Nov 2024

BeiGene to Rename as BeOne Medicines

MT Newswires Live
·
14 Nov 2024

BeiGene Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.
·
14 Nov 2024

BeiGene: Strong Buy Recommendation Driven by Impressive Sales Growth and Promising Pipeline

TIPRANKS
·
14 Nov 2024

BeiGene’s Strong Financial Performance and Growth Potential Justifies Buy Rating

TIPRANKS
·
14 Nov 2024

Beigene Ltd : Jefferies Raises Target Price to $286 From $284

THOMSON REUTERS
·
13 Nov 2024

BeiGene’s Financial and Market Challenges: Navigating Risks in Drug Acceptance, Competition, and Geopolitical Tensions

TIPRANKS
·
13 Nov 2024

Decoding BeiGene Ltd (BGNE): A Strategic SWOT Insight

GuruFocus.com
·
13 Nov 2024

BeiGene Swings to Loss in Q3; Hong Kong Shares Slide 3%

MT Newswires Live
·
13 Nov 2024

Beigene Ltd reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
12 Nov 2024

BeiGene Swings to Q3 Net Loss, Revenue Rises

MT Newswires Live
·
12 Nov 2024

BeiGene Ltd. Unveils Q3 2024 Financial Highlights

TIPRANKS
·
12 Nov 2024

BeiGene Q3 2024 GAAP EPADS $(1.15) Beats $(1.20) Estimate, Sales $1.00B Beat $979.78M Estimate

Benzinga
·
12 Nov 2024

BeiGene: Strong Revenue Outlook and Innovative Cancer Treatments Drive Buy Recommendation

TIPRANKS
·
11 Nov 2024

Beigene Ltd expected to post a loss of $1.20 a share - Earnings Preview

Reuters
·
08 Nov 2024

Stock Track | BeiGene Stock Plunges Amid Investor Concerns Over Financial Position and Regulatory Hurdles

Stock Track
·
07 Nov 2024